Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Roderick

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Nephron. Clinical Practice|April 4, 2013
Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3Simon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
BMC Family Practice|June 27, 2013
Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary careSimon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 31, 2014
Skin autofluorescence and all-cause mortality in stage 3 CKDSimon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
BMC Nephrology|December 22, 2020
Correction to: The burden of comorbidity in people with chronic kidney disease stage 3: a cohort studySimon D S Fraser, Paul J Roderick, Carl R May, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 26, 2011
Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkersPaul A Scott, Paul A Townsend, Leong L Ng, et al.
BMJ Open|August 15, 2020
Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016Hilda O Hounkpatin, S Harris, Simon D S Fraser, et al.
Kidney International|November 10, 2020
A propensity score-matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipientsAilish Nimmo, John L Forsyth, Gabriel C Oniscu, et al.
BMC Nephrology|December 2, 2015
The burden of comorbidity in people with chronic kidney disease stage 3: a cohort studySimon D S Fraser, Paul J Roderick, Carl R May, et al.
Journal of Hepatology|January 27, 2016
Type 2 diabetes and risk of hospital admission or death for chronic liver diseasesSarah H Wild, Joanne R Morling, David A McAllister, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2009
CKD and mortality risk in older people: a community-based population study in the United KingdomPaul J Roderick, Richard J Atkins, Liam Smeeth, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Nephron. Clinical Practice|April 4, 2013
Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3Simon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
BMC Family Practice|June 27, 2013
Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary careSimon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 31, 2014
Skin autofluorescence and all-cause mortality in stage 3 CKDSimon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
BMC Nephrology|December 22, 2020
Correction to: The burden of comorbidity in people with chronic kidney disease stage 3: a cohort studySimon D S Fraser, Paul J Roderick, Carl R May, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 26, 2011
Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkersPaul A Scott, Paul A Townsend, Leong L Ng, et al.
BMJ Open|August 15, 2020
Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016Hilda O Hounkpatin, S Harris, Simon D S Fraser, et al.
Kidney International|November 10, 2020
A propensity score-matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipientsAilish Nimmo, John L Forsyth, Gabriel C Oniscu, et al.
BMC Nephrology|December 2, 2015
The burden of comorbidity in people with chronic kidney disease stage 3: a cohort studySimon D S Fraser, Paul J Roderick, Carl R May, et al.
Journal of Hepatology|January 27, 2016
Type 2 diabetes and risk of hospital admission or death for chronic liver diseasesSarah H Wild, Joanne R Morling, David A McAllister, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 28, 2009
CKD and mortality risk in older people: a community-based population study in the United KingdomPaul J Roderick, Richard J Atkins, Liam Smeeth, et al.
Pageof 9